NCT05161195 2026-02-02
Roll-over Study to Allow Continued Access to Ribociclib
Novartis
Phase 4 Active not recruiting
Clinical Trials
6 trialsNCT05754528 2025-12-17
REaCT-TEMPO
Ottawa Hospital Research Institute
Phase 4 Active not recruiting
NCT04549207 2025-11-28
Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer
Ottawa Hospital Research Institute
Phase 4 Active not recruiting
NCT04921137 2025-11-20
Evaluating Harms and Benefits of Endocrine Therapy in Patients ≥70 Years of Age With Lower Risk Breast Cancer
Ottawa Hospital Research Institute
Phase 4 Active not recruiting
NCT05486182 2025-08-14
ESTROTIMP
GE Healthcare
Phase 4 Active not recruiting
NCT02004834 2024-12-06
Levobupivacaine and Lidocaine for Paravertebral Block Causes Greater Hemodynamic Oscillations Than Levobupivacaine
University Hospital Dubrava
Phase 4 Active not recruiting